Litcius/Paper detail

First-line Immunotherapy-based Combinations for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis

Fahad Quhal, Keiichiro Mori, Andreas Bruchbacher, Irene Resch, Hadi Mostafaei, Benjamin Pradère, Victor M. Schuettfort, Ekaterina Laukhtina, Shin Egawa, Harun Fajković, Mesut Remzi, Shahrokh F. Shariat, Manuela Schmidinger

2021European Urology Oncology139 citationsDOI

Topics & Concepts

NivolumabIpilimumabMedicinePembrolizumabOncologyInternal medicineRenal cell carcinomaCabozantinibAdverse effectProgression-free survivalImmunotherapyCancerOverall survivalRenal cell carcinoma treatmentCancer Immunotherapy and BiomarkersFerroptosis and cancer prognosis
First-line Immunotherapy-based Combinations for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis | Litcius